Indications and uses
A homeopathic combination for symptomatic treatment after contact with poison ivy or oak. Skin breaks out with red, swollen, intensely itching, burning, watery blisters sometimes followed by oozing or crusting.
A homeopathic combination for symptomatic treatment after contact with poison ivy or oak. Skin breaks out with red, swollen, intensely itching, burning, watery blisters sometimes followed by oozing or crusting.
Adults Dissolve 2-3 tablets under tongue every 2 hours as needed, then 4 times per day. Children 6-12 years 1/2 of adult dose.
Drug Facts
Active ingredients | Purpose |
Croton Tiglium 6X HPUS | itching, oozing eruptions |
Rhus Toxicodendron 6X HPUS | red, swollen eruptions with itching |
Xerophyllum 6X HPUS | itching, stinging |
“HPUS” indicates the active ingredients are in the official Homeopathic Pharmacopœia of the United States.
A homeopathic combination for symptomatic treatment after contact with poison ivy or oak. Skin breaks out with red, swollen, intensely itching, burning, watery blisters sometimes followed by oozing or crusting.
As with any drug, ask a doctor before use if pregnant or nursing.
Contact a physician if symptoms persist for 7 days or more.
Keep this and all medications out of the reach of children.
Do not use if imprinted tamper band is broken or missing.
In case of accidental overdose contact a medical professional or Poison Control Center immediately. Hyland’s may also be contacted for emergency information about our products 24 hours a day, 7 days per week at (800) 624-9659.
Adults | Dissolve 2-3 tablets under tongue every 2 hours as needed, then 4 times per day. |
Children 6-12 years | 1/2 of adult dose. |
(800) 624-9659
Lactose, NF
A homeopathic combination for symptomatic treatment after contact with poison ivy or oak. Skin breaks out with red, swollen, intensely itching, burning, watery blisters sometimes followed by oozing or crusting.
Hyland's®
HOMEOPATHIC
POISON
IVY/OAK
Natural Relief for Itching, Burning and
Crusting Skin Due to Exposure to Poison
Ivy or Oak.
50 TABLETS
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CROTON TIGLIUM SEED | ACTIVE INGREDIENT | 0HK2GZK66E | 1 | |
| TOXICODENDRON RADICANS LEAF | ACTIVE INGREDIENT | CDH3461U7L | 1 | |
| XEROPHYLLUM ASPHODELOIDES | ACTIVE INGREDIENT | 9I4XB1GP2B | 1 | |
| CROTON TIGLIUM SEED | ACTIVE MOIETY | 0HK2GZK66E | 1 | |
| TOXICODENDRON RADICANS LEAF | ACTIVE MOIETY | CDH3461U7L | 1 | |
| XEROPHYLLUM ASPHODELOIDES | ACTIVE MOIETY | 9I4XB1GP2B | 1 | |
| Lactose | INACTIVE INGREDIENT | J2B2A4N98G | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54973-1130 | 54973-1130-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE | J2B2A4N98G | IACT |
| TOXICODENDRON RADICANS LEAF | CDH3461U7L | ACTIB |
| CROTON TIGLIUM SEED | 0HK2GZK66E | ACTIB |
| XEROPHYLLUM ASPHODELOIDES | 9I4XB1GP2B | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Lactose | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | SOLUTION / RECTAL | 8 %w/v | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| Lactose | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| Lactose | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d450b424-2d66-86e0-e053-2995a90ab15e | a64ec235-050a-4cf6-ba4d-22ed5c1a1363 | 2021-12-29 | Warnings | a64ec235-050a-4cf6-ba4d-22ed5c1a1363 |
Adverse event summaries are temporarily unavailable. Other product information remains available.